The complete bariatric treatment overview for international patients.
Sleeve gastrectomy, assessment, surgery, recovery and travel planning.
Roux-en-Y gastric bypass, suitability, recovery and follow-up.
OAGB / mini bypass options and how they differ from other pathways.
Intragastric balloon options, eligibility, placement, removal and weight-management support.
Endoscopic stomach reduction, candidacy and recovery.
Revision after previous weight-loss surgery, assessment and options.
Band removal, conversion and revision planning.
Compare mechanisms, trade-offs, recovery and long-term follow-up.
Compare surgical and endoscopic weight-loss pathways.
BMI, obesity-related conditions, assessment and candidacy.
How metabolic surgery may affect diabetes and related disease.
Sleep apnoea, hypertension, fatty liver and other comorbidities.
Clinical, nutritional and practical preparation before surgery.
The multidisciplinary assessment before bariatric treatment.
Hospital stay, early recovery, activity and warning signs.
Diet stages, protein, hydration, vitamins and long-term nutrition.
How weight change can develop and why results vary.
Short- and long-term risks, safety systems and follow-up.
Why regain can happen and how it is assessed.
Understand package prices, exclusions and case-specific costs.
Compare multidisciplinary programmes, surgeons and support.
Build a realistic hospital, recovery and flight timeline.
Bring treatment, accommodation, transfers and follow-up together.
Metabolic care continues after the flight home.
Bariatric treatment changes eating, nutrition and follow-up as well as weight. The JLIT pathway therefore treats pre-operative assessment, diet progression, supplements, metabolic monitoring and home-country handover as part of the treatment plan — not small print after surgery.
For patients with type 2 diabetes or other obesity-related conditions, the metabolic pathway matters just as much as the number on the scales.
